The Best Yielding Large Cap Healthcare Dividend Stocks

It’s very important to know what yields are traded within a sector or industry in order to compare risks and premiums. I made a screen of the best yielding large capitalized healthcare stocks. 38 companies from the healthcare sector have a market capitalization over USD 10 billion and 29 of them pay dividends.

The ten best yielding stocks come from the major drug manufacturing industry which is an unbeaten dividend paying industry despite the burdens of margin pressure due to patent losses and budget cuts from the public and insurance sector. All events lead to slowing growth. The second best dividend industry is the medical instruments and equipment industry.

Below the best yielding large caps is only one high yield and ten stocks yielding over three percent.

AstraZeneca (NYSE:AZN) has a market capitalization of $56.28 billion. The company employs 57,200 people, generates revenues of $33,591.00 million and has a net income of $10,016.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $14,792.00 million. Because of these figures, the EBITDA margin is 44.04 percent (operating margin 38.09 percent and the net profit margin finally 29.82 percent). 

Financial Analysis: The total debt representing 17.66 percent of the company’s assets and the total debt in relation to the equity amounts to 40.13 percent. Due to the financial situation, a return on equity of 42.98 percent was realized. Twelve trailing months earnings per share reached a value of $6.49. Last fiscal year, the company paid $2.80 in form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 6.82, P/S ratio 1.66 and P/B ratio 2.44. Dividend Yield: 6.38 percent. The beta ratio is 0.60.



GlaxoSmithKline (NYSE:GSK) has a market capitalization of $115.56 billion. The company employs 97,389 people, generates revenues of $44,452.20 million and has a net income of $8,858.95 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $14,945.63 million. Because of these figures, the EBITDA margin is 33.62 percent (operating margin 28.50 percent and the net profit margin finally 19.93 percent).

Financial Analysis: The total debt representing 36.27 percent of the company’s assets and the total debt in relation to the equity amounts to 185.52 percent. Due to the financial situation, a return on equity of 62.19 percent was realized. Twelve trailing months earnings per share reached a value of $3.25. Last fiscal year, the company paid $2.27 in form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 14.34, P/S ratio 2.63 and P/B ratio 8.95. Dividend Yield: 4.92 percent. The beta ratio is 0.61.





Eli Lilly & Co. (NYSE:LLY) has a market capitalization of $47.86 billion. The company employs 38,080 people, generates revenues of $24,286.50 million and has a net income of $4,347.70 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $6,657.00 million. Because of these figures, the EBITDA margin is 27.41 percent (operating margin 22.03 percent and the net profit margin finally 17.90 percent). 

Financial Analysis: The total debt representing 20.76 percent of the company’s assets and the total debt in relation to the equity amounts to 51.60 percent. Due to the financial situation, a return on equity of 33.49 percent was realized. Twelve trailing months earnings per share reached a value of $3.86. Last fiscal year, the company paid $1.96 in form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 10.69, P/S ratio 1.98 and P/B ratio 3.54. Dividend Yield: 4.74 percent. The beta ratio is 0.68.







Take a closer look at the full table of the best yielding large capitalized dividend stocks. The average price to earnings ratio (P/E ratio) amounts to 15.75 and forward P/E ratio is 11.56. The dividend yield has a value of 2.50 percent. Price to book ratio is 3.20 and price to sales ratio 2.39. The operating margin amounts to 19.64 percent.

Here is the full table with some fundamentals (TTM):

Related stock ticker symbols:
AZN, GSK, LLY, SNY, NVS, MRK, BMY, PFE, JNJ, ABT, MDT, BAX, STJ, BDX, TEVA, AMGN, NVO, WLP, COV, AET, SYK, FMS, HUM, UNH, ZMH, TMO, SHPGY, AGN, CI